Publication | Closed Access

Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway

InflammationLiver FibrosisHepatologyAutoimmune DiseaseBiliary TractLiver PhysiologyPathogenesisImmunologyPathologyPrimary Sclerosing CholangitisHepatology InflammationBiliary DisorderPrevotella CopriLiver DiseasePrimary Biliary CirrhosisCholangiopathiesMedicine